SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / September 6, 2022 / Occlutech Holding AG Occlutech Holding AG ("Occlutech"), one of the world's leading providers of minimally invasive structural heart ...

SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / February 1, 2023 / Occlutech Holding AG Occlutech Holding AG ("Occlutech"), one of the world's leading providers of minimally invasive structural heart disease ...

SCHAFFHAUSEN, Switzerland, Jan. 19, 2021 /PRNewswire/ -- Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough ...

BENGALURU, Feb 13 (Reuters) - Alkem Laboratories' (ALKE.NS), opens new tab medical devices unit will buy up to a 55% stake in Switzerland's Occlutech Holding for 99.4 million euros ($118 million), the ...

SCHAFFHAUSEN, Switzerland, Feb. 24, 2021 /PRNewswire/ -- Occlutech, a privately-held company, announced today the completion of patient enrolment in its pilot study to assess safety and efficacy of ...

Occlutech showed a strong revenue increase in Q1 2022, with March approaching an all-time high. All markets performed well with the best result in the company's history from sales in direct markets.

SCHAFFHAUSEN, Switzerland, June 1, 2021 /PRNewswire/ -- Occlutech AG ("Occlutech" or the "Company") today announces that the planned recruitment of 180 patients has been reached in the Company's trial ...

St. Jude Medical’s AGA Medical subsidiary has filed two new lawsuits against an European company with which it has had legal tussles that date back to 2006. The Little Canada, Minnesota-based medical ...

Occlutech, a leading European developer of medical implants treating structural heart disease such as PFO, ASD and LAA today announced the closing of a 15 million Euro investment into Occlutech. The ...

SCHAFFHAUSEN, Switzerland, Jan. 19, 2021 /CNW/ -- Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device ...